Collins Helen Louise
CHIEF MEDICAL OFFICER · 23 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 2,599 | $43.87 | $114,018.39 | filing |
| 2026-06-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,268 | $42.83 | $54,304.64 | filing |
| 2026-06-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,133 | $44.74 | $50,693.82 | filing |
| 2026-06-17 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 5,000 | $2.48 | $12,400.00 | filing |
| 2026-05-18 | ELVN | Enliven Therapeutics, Inc. | Sale | 3,475 | $39.53 | $137,380.65 | filing |
| 2026-05-18 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,302 | $40.25 | $52,401.98 | filing |
| 2026-05-18 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 5,000 | $2.48 | $12,400.00 | filing |
| 2026-05-18 | ELVN | Enliven Therapeutics, Inc. | Sale | 223 | $41.21 | $9,188.76 | filing |
| 2026-04-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 2,441 | $48.06 | $117,303.48 | filing |
| 2026-04-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 2,419 | $47.39 | $114,635.44 | filing |
| 2026-04-17 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 5,000 | $2.48 | $12,400.00 | filing |
| 2026-04-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 140 | $45.81 | $6,413.50 | filing |
| 2026-03-25 | ELVN | Enliven Therapeutics, Inc. | Sale | 40,000 | $35.10 | $1.4M | filing |
| 2026-03-25 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 40,000 | $2.48 | $99,200.00 | filing |
| 2026-03-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 5,000 | $27.76 | $138,800.00 | filing |
| 2026-03-17 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 5,000 | $2.48 | $12,400.00 | filing |
| 2026-03-10 | ELVN | Enliven Therapeutics, Inc. | Sale | 10,129 | $30.19 | $305,826.92 | filing |
| 2026-03-10 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 10,129 | $2.48 | $25,119.92 | filing |
| 2026-03-09 | ELVN | Enliven Therapeutics, Inc. | Sale | 29,871 | $30.02 | $896,811.06 | filing |
| 2026-03-09 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 29,871 | $2.48 | $74,080.08 | filing |
| 2026-02-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 45,000 | $26.17 | $1.2M | filing |
| 2026-02-17 | ELVN | Enliven Therapeutics, Inc. | Option exercise | 45,000 | $2.48 | $111,600.00 | filing |
| 2026-02-12 | ELVN | Enliven Therapeutics, Inc. | Award | 25,000 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.